M28 Capital Management LP Nex Immune, Inc. Transaction History

M28 Capital Management LP

  • $86.7 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
BUY
$4.11 - $15.13 $548,446 - $2.02 Million
133,442 New
133,442 $615,000

About NexImmune, Inc.

NEXI Quotes by TradingView
  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $5.07M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track M28 Capital Management LP Portfolio

Follow M28 Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M28 Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on M28 Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email